Phathom Pharmaceuticals, Inc. · NASDAQ:PHAT
Phathom Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 153 institutions reported holding Phathom Pharmaceuticals, Inc., 86.5% of its shares. Largest: Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Phathom Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 12.5M | 15.3% | no change | Nov 16, 2026 |
| Medicxi Ventures Management (Jersey) Ltd | 7.46M | 9.2% | no change | Nov 2, 2026 |
| BlackRock | 5.25M | 6.5% | +721K | Nov 13, 2026 |
| Vanguard | 3.87M | 4.8% | +844 | Nov 13, 2026 |
| Carlyle Group Inc. | 3.5M | 4.3% | no change | Nov 6, 2026 |
| Wasatch Advisors LP | 2.94M | 3.6% | +1.64M | Oct 13, 2026 |
| Franklin Templeton | 2.41M | 3.0% | +436K | Nov 12, 2026 |
| Millennium | 2.4M | 3.0% | −975K | Nov 16, 2026 |
| GW&K Investment Management, LLC | 2.13M | 2.6% | −38,016 | Nov 10, 2026 |
| 683 Capital Management, LLC | 2M | 2.5% | +150K | Nov 16, 2026 |